wondering what consensus is on leerink biopharma? huge growth in the last couple years, ecm ranked number 1. is it effectively an eb for the industry at this point? where does it rank
| +119 | I think I’m logging off after ER visit | 23 | 1d |
| +101 | Is it Bad That I ALREADY Don’t Care? | 31 | 6h |
| +94 | AI Creating More Work | 29 | 12m |
| +91 | Senior Banker's Guide to IB Recruiting / Group Placement (with a Healthcare Bent) | 10 | 10h |
| +62 | Shit PWP Culture | 43 | 7h |
| +59 | Consulting Son or CorpDev Daughter? | 6 | 4d |
| +44 | How easy was recruiting for you? | 21 | 5d |
| +36 | 22yo IB Analyst just had mental health breakdown | 11 | 1d |
| +25 | Is the life of a VP at a 'top-bank' really good? | 6 | 17h |
| +22 | Law school instead of MBA for RX Banking | 3 | 1d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Based on the most helpful WSO content, Leerink has shown significant growth in recent years, particularly in the biopharma and healthcare sectors. It has been noted for its strong performance in ECM (Equity Capital Markets), even being ranked number one in this area. However, whether it is considered an Elite Boutique (EB) is still up for debate.
While Leerink's growth is impressive, and it is a top destination for those focusing on healthcare and life sciences, there is skepticism about whether it can consistently compete for $10+ billion M&A deals, a hallmark of true EBs. Comparisons to firms like Qatalyst in healthcare (HC) have been made, but achieving that level is seen as a tough challenge.
In terms of ranking, Leerink is certainly regarded as a top-end shop for healthcare, making it a strong platform for future opportunities in private equity (PE), growth equity (GE), and venture capital (VC) recruiting, especially in life sciences.
Sources: Is Leerink Turning Into EB?, Is Leerink Turning Into EB?, Is SVB Leerink Becoming an EB?, What's your Top Stock Pick for 2017
would recommend taking a look at these two threads on WSO.
[Early 2026] The Definitive and Data-Driven Healthcare IB Group Rankings (Biopharma + Broader HC)
Leerink Partners Culture?
Culture is very tough. Good luck.
It’s “Leerink”, good luck
Et enim molestias voluptate dolorem corporis ut et est. Ad quos facere rem perferendis modi. Qui nihil possimus et nostrum voluptas sit. Nisi necessitatibus exercitationem facere.
Et est impedit necessitatibus ullam blanditiis numquam magnam. Suscipit blanditiis dolor molestias non cum est ex maiores. Quasi maxime soluta eos. Earum molestias itaque ullam qui nostrum.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...